Feasibility of Remote MCE for Upper GI Tract Examination Under Five-generation Network
Gastrointestinal Disease
About this trial
This is an interventional diagnostic trial for Gastrointestinal Disease focused on measuring capsule endoscopy, magnetically, 5G network, telemedicine
Eligibility Criteria
Inclusion Criteria:
- Gender is not limited.
- Patients aged 18 years or older.
- Both inpatients and outpatients.
- Volunteers with or without abdominal complaints.
- Able to provide informed consent.
Exclusion Criteria:
- dysphagia or symptoms of gastric outlet obstruction, suspected or known intestinal stenosis,overt gastrointestinal bleeding,fistulas and strictures;
- history of upper gastrointestinal surgery or suspected delayed gastric emptying;
- Patients with poor general condition,asthma or claus trophobia;
- Implanted metallic devices such as pacemakers,defibrillators, artificial heart valves or joint prostheses;
- Pregnancy or mentally ill person;
- currently participating in another clinical study;
- communication obstacles persons.
Sites / Locations
- Changhai Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
5G-MCE examination
MCE examination
There will be 20 volunteers assigned to the 5G-MCE system group. These patients will accept the magnetically controlled capsule examination in Yinchuan. After an overnight fasting and drinking 800-1000 mL water and simethicone for gastric dilatation and preparation, the subjects put on the data recorder with the help of the assistant in Yinchuan. Then, the assistant activated the capsule with the capsule locator. The patient is instructed to swallow the capsule with a small amount of water to effectively observe the esophagus and dentate line. After the capsule entering into the stomach, the examination will be performed through the 5G-MCE system by the endoscopist (W.Z.), with experience of more than 1000 cases of MCE operation, in Shanghai.
There will be 20 volunteers assigned to the MCE system group as comparator group. After an overnight fasting and drinking 800-1000 mL water and simethicone for gastric dilatation and preparation, the subjects put on the data recorder with the help of the endoscopist. Then, the endoscopist activated the capsule with the capsule locator. The patient is instructed to assume the left lateral decubitus position and to swallow the capsule with a small amount of water to effectively observe the esophagus and dentate line. Then, under the guidance of the endoscopist (W.Z.) face to face, subject continue the examination of stomach and duodenum.